Policies, SOPs, MOPs, Protocols
|
|
- Annabel Harvey
- 7 years ago
- Views:
Transcription
1 PREP Course #6: Policies, SOPs, MOPs, Protocols OH MY! Presented by: Tina Chuck, MPH Manager, Research Policy and Training Research Administration North Shore-LIJ Health System Phone: Cerdi Beltré, CIP, CCRC Administrative Director, Clinical Research Service Director, Clinical Research Operations, NSLIJHS The Feinstein Institute for Medical Research North Shore-LIJ Health System Phone:
2 CME Disclosure Statement The North Shore LIJ Health System adheres to the ACCME s new Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by the North Shore-LIJ for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations. Course Director and Course Planner, Kevin Tracey, MD and Tina Chuck, MPH have nothing to disclose. Tina Chuck, MPH and Cerdi Beltré, CIP, CCRC are the speakers and have nothing to disclose.
3 Class Objectives At the end of today s class you should be able to: 1) Recognize the differences between policies, SOPs, MOPs, and protocols. 2) Explain the usefulness of policies, SOPs, MOPs, and protocols. 3) Demonstrate how to search for health system policy on HealthPort. 4) Apply process mapping when writing SOPs. SOPs Policies Protocols MOPs
4 POLICY Health System; Facility/Department specific STANDARD OPERATING PROCEDURES (SOP) PROTOCOL 1 Protocol per Research Project MANUAL OF OPERATIONS (MOP) 1 MOP per Protocol DEFINITION What is it and how are they different? A predetermined course of action established as a guide toward accepted business strategies and objectives. It can be proposed by a government, party, business, or individual. Detailed, written instructions to achieve uniformity of the performance of a specific function. (ICH GCP 1.55) In simple terms: A written process by which a task can be performed the same way each time. It provides instructions necessary to carry out a policy. A document that describes the objective(s), design, methodology, statistical considerations, and organization of a trial. The protocol usually also gives the background and rationale for the trial, but these could be provided in other protocol referenced documents. (ICH GCP 1.44) A handbook of instructions designed to guide the research team to successfully carry out aspects of a research project according to research protocol. Clinical trial site specific and applicable across protocols
5
6 POLICY STANDARD OPERATING PROCEDURES (SOPs) PROTOCOL MANUAL OF OPERATIONS (MOPs) Benefits Why should I care? Set boundary conditions so that actions and decisions are made consistently in pursuit of an objective; create expectations and guides for actions. Allows management and employees to operate without constant intervention. Reflect the vision/mission of the organization. Provides standardization of processes across protocols at a clinical trial site. Manage compliance obligations Incorporates regulations, GCPs, and institutional policies. Create operational efficiency Ensures processes have been examined and optimized. Training staff Acts as a resource to keep everyone on the same page at all times. Is a road map for the research project. Clearly spells out why you are doing the research, what the research question and data needed to answer the question are, and how to gather and analyze the data. Provides standardization of processes for one particular research protocol. Clearly spells out the who, what, where, when, and how. Training staff Acts as a resource to keep everyone on the same page at all times. Particularly helpful when someone is covering for another due to vacation, sick time, staff turnover, etc.
7 What is the Policy Statement? One-third of all staff must be rated as does not meet expectations. Why SOPs? In this case, without SOPs there would be no standardized written process to detail how this decision is made each time to meet the policy requirements.
8 Case Studies of Human Subjects Research According to Policies, SOPs, Protocol, and MOPs
9 Example 1: Consent POLICY TITLE: Policy GR089 Informed Consent and Recruitment for Human Subject Research SOPs: Informed Consent SOP# 7 Adult and Peds PROTOCOL MANUAL OF OPERATION (MOP) The PI approved by the IRB If greater than minimal risk then investigator will be a Responsible Practitioner defined in NSLIJHS Policy # (Informed Consent and Medical Decision Making for Patients Who Lack Capacity) The CRC or Investigator discusses the informed consent form with the potential study subject If a minor turns 18 during their participation in a study, they will be consented as an adult. Specify how this is done, ex.: For applicable studies, Outlook calendar will be flagged with the birth date of subject which will trigger one month prior. Speak with subject in person or contact the subject via phone, and/or letter to invite/schedule the consent visit. If multiple attempts fail, withdraw the subject as lost to follow-up. One parental signature is required Adults provide consent form self None provided for this protocol. 45 CFR : investigator obtains the legally effective informed consent of the subject or the subject's legally authorized representative.
10 Example 2: Investigative Product POLICY TITLE: Policy GR049 Medications and Investigational New Drugs PI: Ensures that resources necessary to conduct a clinical investigation are available at the designated Department of Pharmacy PRIOR to the study initiation Provides essential documentation for the dispensation of investigational drug(s) THROUGHOUT the study. SOPs: TEST ARTICLE MANAGEMENT SOP# 10 PI: Provides appropriate personnel/department of Pharmacy, with a copy of the approved protocols, consent documents, plus any additional information such as amendments, changes in investigator(s) Maintains secure test article records Administered by individuals that are IRB approved to do so, and at least one of the following Diabetes XYZ PROTOCOL 75 mg TID with food MANUAL OF OPERATION (MOP) Each pill is 25 mg = dispense 3 pills three times daily for the 30 day dosing period. Stored in tightly closed containers and protected from moisture and excessive heat. Room temperature; 15 to 30 C (59 TO 86 F). Locked cabinet in a secure area of the clinical research center or research pharmacy. The research pharmacist/nurse may assume responsibility for drug accountability. GCP E6: The sponsor should determine for the IP, the acceptable storage temperatures, storage conditions and procedures. The sponsor should inform all involved parties of these determinations The investigator should qualified staff and adequate facilities to conduct the trial properly and safely.
11 Example 3: Labs POLICY TITLE: Policy GR080 Human Subject Research Oversight and Monitoring SOPs: Processing of Specimens SOP# 17 Lupus XYZ PROTOCOL MANUAL OF OPERATION (MOP) Comply with ICH E6: Good Clinical Practice (GCP) PI is responsible for complying with protocol Follow the lab manual Follow health system policy Review the protocolspecific laboratory manual Baseline Tests Performed: Chemistry Hematology 24 hr. urine PT, PTT w/inr Ask for clarification before performing the required procedure when information is unclear. Sterile processing Infection control Etc. GCP E6: 6.7 Protocol should specify efficacy parameters, timing for assessing, recording, and analyzing efficacy parameters.
12 Development and Implementation of POLICIES Federal Regulations, Industry Guidance, best practices, etc. Other Policies (i.e. Facility Policies, Departmental Policies) Health System Policies Examples include HS Corporate Compliance policies, HS Human Resources policies, HS OCIO policies, HS Infection Control policies, and HS Research policies.
13 Development and Implementation of NSLIJ Health System Research Policies Governed by health system policy Developing and Revising NSLIJ Health System Administrative Policies and Procedures.
14
15 Development of Health System Research Policies Step 1 Step 2 Step 3 Step 4 Step 5 Draft new policy or revisions to existing policy with policy owner(s) and content experts. 1. Policy Development can take months a lot of thought is put into writing policy by content experts, including those who would be affected by the policy in their day to day tasks. Submit to System Administrative Policy and Procedure Committee (System P&P) and Feinstein Policy and Procedure Committee (Feinstein P&P) for 3 rounds of review. After System P&P approval, submit to System Performance and Improvement Coordinating Group/Clinical Operation Committee (System PICG). 2. Policies are not stagnant; they can change due to After changes System PICG approval, in federal submit regulations, to Feinstein P&P to vote new on adoption of finalized policy if they are applicable to research staff. processes, etc. Changes are limited to what is needed and necessary. Adopted health system research policies are communicated to employees via , trainings, Research Matters newsletter, posted on HealthPort, at meetings, and at the departmental level.
16 Where do you find NSLIJ Health System Policies? Each facility will be listed as you scroll down
17 Development and Implementation of Standard Operating Procedures (SOPs) Governed by: Health system research policy GR095 Requirements of Standard Operating Procedures for Clinical Trial Sites, and A Standard Operating Procedure for maintaining and writing SOPs
18 What does our health system research policy on SOPs say? GR095 Policy Statement: All clinical trial sites conducting clinical trials at or on behalf of the health system must have SOPs as outlined herein. 15 SOPs required for all clinical trial sites; additional 3 required, if applicable. A clinical trial site is defined as the location where clinical research (research involving investigational products such as drugs or devices) is taking place. This can be a site, department, facility, or equivalent.
19 Who is responsible for SOPs at the clinical trial sites? Per Policy GR095: Departmental or Unit leadership, in collaboration with their Principal Investigators (PIs), or designee(s), are responsible for writing, implementing, maintaining, and ensuring compliance with clinical trial SOPs at their clinical trial site(s). TIP: The best person to write what you do is the person who does it!
20 Writing SOPs 1) Develop a template to be used for all SOPs. NOTE: The Clinical Research Service (CRS) provides templates for the different required SOPs on their website. Templates should be modified accordingly to meet your site s needs. If you choose to develop your own template, be sure to include the required elements that are listed in policy GR095 (i.e. objectives, responsibilities, procedures, etc.). 2) Select topics that SOPs will be created for. NOTE: Per health system policy GR095, clinical trial sites are required, but not limited, to have the 15 SOPs that are noted in the policy; and an additional 3 SOPs, if applicable. Non-clinical trial sites are encouraged to have SOPs, but are not required.
21 Process Mapping for Writing SOPs 1) Focus on 1 SOP at a time; 1 process for 1 SOP. i.e. Informed Consent, Disaster Plan, Study Close-Out 2) Write down all the steps currently used to complete the process for that SOP. Example of steps used in informed consent: Step 1: Obtain the consent form. Step 2: Verify that you are using the most current IRB-approved version. Step 3: Provide a copy of the consent form to the subject/representative. 3) Mapping involves taking each step in the process and making it more efficient and easier to follow.
22 Process Mapping for Making a Cup of Coffee Woodin, K. (2004) The CRC s Guide to Coordinating Clinical Research p Centerwatch Primary Step Ensure the coffee maker is ready Add the coffee Add the water Turn on the machine Serve the coffee
23 Process Mapping for Making a Cup of Coffee Secondary Step Ensure the coffee maker is ready Add the coffee Add the water Turn on the machine Serve the coffee Ensure the machine is plugged in Place a filter in the basket Use the carafe to measure the water Wait until the coffee has stopped dripping Ensure carafe is empty and clean Measure the coffee Place the carafe on the heating element
24 Process Mapping for Writing SOPs Process mapping should include input from people involved in all the steps; they are the content experts. Processes should be tested for best practices. Translate the process map into your SOP template. Worksheets, flowcharts, forms, and checklists can be incorporated into your SOPs.
25 Tips for Writing SOPs Use clear, concise language. Use active voice. Avoid names; use titles instead. Write SOPs in the way that would work for your clinical trial site. For example, you can have SOPs that are only applicable to coordinators, or only applicable to investigators, or only applicable to Principle Investigators.
26 Implementing and Monitoring SOPs What does Policy GR095 say? Implementation/Education All SOPs must be designated an effective date. Documentation of approval must be obtained with appropriate dated signatures. All applicable staff should receive education for new and revised SOPs; education must be documented. SOPs must be accessible to staff in a centralized location, either electronically or via paper copy. Revisions/Archiving SOPs must be reviewed on a regular basis (usually every 2 years at a minimum) for possible revisions due to changes in regulations or site procedures. Previous versions of SOPs must be retained in a centralized location accessible to staff, either electronically or via paper copy. In the event of a regulatory audit, the auditor may audit a study against the SOP that was in effect at the time of study conduct.
27 Tips for Implementing and Monitoring SOPs Introduce SOPs gradually so that staff do not become overwhelmed. Prioritize most relevant SOPs and present them first. Revise SOPs on a regular basis due to changes in process, regulations, and policies.
28 Educating/Training Staff on SOPs Applicable staff should have SOP training. Best to have the author(s) train team members on the SOP. Education/training must be documented. SOP should be easily accessible to staff.
29 Q: Where can you find NSLIJ Clinical Trial Site SOP Templates? A:
30 Standard Operating Procedures Required Standard Operating Procedures for SOPs Coordinator Qualification, Responsibilities and Training Investigator Qualification, Responsibilities and Training Departmental Assessment of Protocol Feasibility Data Management and Documentation Recruitment and Retention of Subjects Informed Consent Required, Cont. Resolving and Reporting Protocol Deviations, Violations, AE/SAEs, Unanticipated Problems, and Documentation Sponsor Interactions Test Article Management Quality Control & Assurance Study Close-Out Study Confidentiality and Security Disaster Plan Patient Complaint Process As needed Point of Care Laboratory Testing Processing of Specimens Safety
31 Differentiating NSLIJHS in Clinical Research Operations 1) Experienced staff 1 5 2) Established procedures ) Access to large #s of patients 4) Mature CT infrastructure 5) Investigators who practice in settings relevant to the questions being asked 6) Performance 7) Quality 8) Nimble? Bullets 1-5 from Institute of Medicine (IOM) discussion paper: Developing a Clinical Trials Infrastructure in the United States, May BMW M3 V8 Engine
32 Questions For general questions regarding SOPs and clinical research operations, contact: Cerdi Beltré, CIP, CCRC Administrative Director, Clinical Research Service The Feinstein Institute for Medical Research North Shore-LIJ Health System Phone: For general questions regarding policies, contact: Tina Chuck, MPH Manager, Research Policy and Training Research Administration North Shore-LIJ Health System Phone:
PREP Workshop #31: Preparing for Certification as a Clinical Research Coordinator
PREP Workshop #31: Preparing for Certification as a Clinical Research Coordinator Presented by: Susan Ray, MS, CCRC Supervisor Research Coordination Clinical Research Service CME Disclosure Statement The
More informationSocial Media Research 101. By: Dorean J. Flores, CIP Manager, North Shore-LIJ IRB
Social Media Research 101 By: Dorean J. Flores, CIP Manager, North Shore-LIJ IRB CME Disclosure Statement The North Shore LIJ Health System adheres to the ACCME s new Standards for Commercial Support.
More informationPREP Course #17: Are we there yet? Achieving Enrollment Success
PREP Course #17: Are we there yet? Achieving Enrollment Success Cerdi Beltre, CIP, CCRP Administrative Director, Clinical Research Service Director, Clinical Research Operations, NSLIJ 516-562-0340, cbeltre@nshs.edu
More informationPREP Course #27: Medical Device Clinical Trial Management
PREP Course #27: Medical Device Clinical Trial Management Presented by: Evelyn Huang Jeffrey Revello Office of Research Compliance North Shore-LIJ Health System CME Disclosure Statement The North Shore
More informationStudy Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)
Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,
More informationNo. 706. Page 1 of 5. Issue Date 4/21/2014
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
More informationSubject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
More informationThe Importance of Following the PROTOCOL in Clinical Trials
The Importance of Following the PROTOCOL in Clinical Trials Presentation Objectives: Upon completion of this presentation, participants will be able to: Describe the following terms: Protocol, Protocol
More informationThe Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
More informationThis unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an
Music No audio Please review information shown to understand the general course navigation and available resources. Resources, such as the audio script, example forms, and website links, can be accessed
More informationCLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities
More informationRecruitment of Research Participants. Dorean J. Flores IRB Manager
Recruitment of Research Participants Dorean J. Flores IRB Manager CME Disclosure Statement The North Shore LIJ Health System adheres to the ACCME s new Standards for Commercial Support. Any individuals
More informationPREP WORKSHOP #11 Investigational Drug Disposal
PREP WORKSHOP #11 Investigational Drug Disposal Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, Clinical Research Service Miyuki Yoshida-Hay, RSO, MLSO, CHSP Safety Office,
More informationDifferential Training by Job Function ACRP Job Analysis Results
Differential Training by Job Function ACRP Job Analysis Results Morgean Hirt, ACA, Director of Certification Association of Clinical Research Professionals Disclaimer The views and opinions expressed in
More informationROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
More informationHow To Write A Binder Tab
Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing
More informationINTERIM SITE MONITORING PROCEDURE
INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.
More informationGLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
More informationFriday, May 2. Clinical Trials: Is Your Staff Competent? Session 10:15 11:45 am Ballroom C
Session 10:15 11:45 am Ballroom C Clinical Trials: Is Your Staff Competent? What fundamental skills and knowledge should clinical trials nurses have? In response to questions from its members about how
More informationQuality Monitoring Checklist
Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor
More informationPrincipal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
More informationThe Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
More informationNEGOTIATING CLINICAL TRIAL BUDGETS. Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N.
NEGOTIATING CLINICAL TRIAL BUDGETS Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N. A.B.N. Amateur Budget Negotiator OVERVIEW Budget Types Analyzing the Protocol Negotiating the Contract Discussion / Tips
More informationGood Documentation Practices
Good Documentation Practices Clinical Research Operations & Regulatory Support Ann Glasse, RN, BSN, MBA Director, Regulatory Support Author: Johanna Stamates, RN, MA, CCRC, CHRC Objectives Recognize the
More informationRoles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
More informationData Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International
Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,
More informationPre-Questions. Mastering Clinical Research July 29, 2015
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
More informationElectronic Medical Records and Source Data for Research: What s the Difference?
Electronic Medical Records and Source Data for Research: What s the Difference? Tammy Anderson, CCRC, CCRA, CRCP Director, Clinical Trials Office Virginia Commonwealth University Research Coordinator 4
More informationThe Role of the Clinical Trials Nurse. Objectives. CTN: Protocol Development
The Role of the Clinical Trials Nurse Elizabeth Ness, RN, MS Director, Staff Development Center for Cancer Research, NCI Objectives Discuss the clinical trials nurse s involvement in protocol development.
More informationData Management in Clinical Trials
Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 19, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
More informationThe Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
More informationA Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky
A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators
More informationTo Certify or Not to Certify
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus November
More informationTo Certify or Not to Certify Sandra Halvorson, BA, CCRP
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II We have no financial relationships
More informationDHHS/NIH/OD/OIR/OHSRP 1/2/2015
DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.
More informationReliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s)
Name of Organization Providing IRB Review: Stony Brook University ( SBU IRB ) Name of Institution Relying on the SBU IRB ( Institution ): Latest AAHRPP Accreditation Date (if applicable) OHRP Federal Wide
More informationResearch Administration. Clinical Trial Administration Part I: Overview of Clinical Trial Management. (Presented November 12 th and 14 th 2013)
Research Administration Clinical Trial Administration Part I: Overview of Clinical Trial Management (Presented November 12 th and 14 th 2013) Objective Provide an overview of the clinical trials lifecycle
More informationCNE Disclosures. To change this title, go to Notes Master
CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion
More informationCLINICAL RESEARCH PROTOCOL CHECKLIST
CLINICAL RESEARCH PROTOCOL CHECKLIST [taken from ICH GCP : Guidance for Industry, Good Clinical Practice: Consolidated Guidance, Revision 1 (R1) June 1996] ICH GCP, Section 6. CLINICAL TRIAL PROTOCOL AND
More informationRD SOP17 Research data management and security
RD SOP17 Research data management and security Version Number: V2 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive lead: Medical Director
More informationCore Training Outline
Core Training Outline Modules: 1) Study Design 2) PI Oversight 3) Financial Management 4) Study Operations 5) Recruitment & Retention 6) Informed Consent 7) Investigational Products 8) Subject Safety 9)
More informationMarie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager
Standard Operating Procedures (SOP) for: Monitoring SOP 28 Version 7.0 Number: Number: Effective Date: 29 th November 2015 Review Date: 6 th January 2017 Author: Reviewer: Reviewer: Authorisation: Name
More informationData Management Unit Research Institute for Health Sciences, Chiang Mai University
Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data
More informationGuidance on IRB Continuing Review of Research
NOTE: THIS GUIDANCE SUPERSEDES OHRP S JANUARY 15, 2007 GUIDANCE ENTITILED GUIDANCE ON CONTINUING REVIEW. CLICK HERE FOR THE JANUARY 15, 2007 GUIDANCE. Office for Human Research Protections Department of
More informationVertex Investigator-Initiated Studies Program Overview
Vertex Investigator-Initiated Studies Program Overview Our Goal To support independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations,
More informationWhat is necessary to provide good clinical data for a clinical trial?
What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction
More informationCatherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research
A Practical Guide on Applying USF HRPP P&Ps in the Clinical Setting Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research Learning Objectives Recognize the
More informationClaim of Exemption Form Page 1 of 6
Claim of Exemption Form Page 1 of 6 Principal Investigator: Phone: Project or Protocol Title: Contact Person: Address: Phone: Fax: E-mail: Copy of Principal Investigator s CV attached SPONSOR / FUNDING
More informationDecember 13, 2011 Maureen Coyne
December 13, 2011 Maureen Coyne No industry relationships No financial conflicts of interests Recent experience weighted toward industrysponsored clinical trials Information based on my experiences IRB
More informationR&D Administration Manager. Research and Development. Research and Development
Document Title: Document Number: Patient Recruitment SOP031 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration Manager,
More informationData Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.
Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of
More informationGuidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues
Office for Human Research Protections (OHRP) Department of Health and Human Services (HHS) Guidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues This guidance represents
More informationPREP Course # 25: Going Electronic?
PREP Course # 25: Going Electronic? Presented by: Cerdi Beltre, Administrative Director, Clinical Research Service Martin L. Lesser, PhD, EMT-CC, Director and Investigator, Biostatistics Unit David Ballard,
More informationBarnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
More informationROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
More informationGood Clinical Practice 101: An Introduction
Good Clinical Practice 101: An Introduction Presented by: Lester Jao Lacorte, MD Medical Officer Commissioner s Fellow Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological
More informationComprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
More informationIntroduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6
Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication
More information2 Applicability: Effective Date: 1/15/2010 Revised: 8/13/2010, 9/10/10, 5/9/14
2 Applicability: Effective Date: 1/15/2010 Revised: 8/13/2010, 9/10/10, 5/9/14 NDSU research may involve the collaboration or assistance of other research institutions, schools, hospitals, clinics, private
More informationTHE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA
THE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA Godwin D. Ndossi, PhD Chairman Tanzania National Health Research Forum Formerly, Managing Director Tanzania Food and Nutrition Centre
More informationGuidance to Research Ethics Committees on Initial Facility Assessment
Guidance to Research Ethics Committees on Initial Facility Assessment Introduction One of the roles of a Research Ethics Committee is to provide an opinion on a proposed study, based on the suitability
More informationHuman Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
More informationQUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
More informationChildren's Hospital, Boston (Draft Edition)
Children's Hospital, Boston (Draft Edition) The Researcher's Guide to HIPAA Evervthing You Alwavs Wanted to Know About HIPAA But Were Afraid to Ask 1. What is HIPAA? 2. What is the Privacy Rule? 3. What
More informationHIPAA Medical Billing Requirements For Research
The Health Insurance Portability and Accountability Act (HIPAA) Excerpted from the UTC IRB Policy June 2008 Table of Contents PART V: The Health Insurance Portability and Accountability Act (HIPAA)...
More informationMedical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
More informationNova Southeastern University IRB - Consent Form Checklist Version Date: 02/17/2010
Nova Southeastern University IRB - Consent Form Checklist Version Date: 02/17/2010 This form is intended to assist researchers in creating consent and assent forms. Informed consent is one of the primary
More informationSharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com Education: Masters of Science, Healthcare Administration, Capital City University,
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: SOP number: SOP category: Document Control GE-003 General SOP history Version number: 01 Version date: 1 March 2013 Effective
More informationCLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
More informationInvestigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)
March 1, 2006 M E M O R A N D U M F O R R E C O R D TO: FROM: SUBJECT: Deans Department Chairs Principal Investigators Brian Herman, Ph.D. Vice President for Research Investigator responsibilities for
More informationRECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.
More informationEstablishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director
More informationEthics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
More informationJoint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
More informationRole of IRB/IEC in GCP. Benjamin Kuo, MD, Dr.PH, CIP.
Role of IRB/IEC in GCP Benjamin Kuo, MD, Dr.PH, CIP. Institutional Review Board (IRB) An independent body constituted of medical, scientific and non scientific members Responsible for ensuring protection
More informationHow Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation
More informationVersion history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy
Trial name: HOVON xxx yyy Sponsor: HOVON Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy QRMP authors
More informationEssential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
More informationFINAL DOCUMENT. Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers Part 1: General Requirements
GHTF/SG4/N28R4:2008 FINAL DOCUMENT Title: Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers Authoring Group: GHTF Study Group 4 Endorsed by: The Global Harmonization
More informationThis policy applies to all clinical research conducted at Beaumont Health System.
CLINICAL RESEARCH QUALITY AND PROCESS IMPROVEMENT PROGRAM 113 1 of 6 PURPOSE Prior The purpose of this policy is to provide an overview of the Clinical Research Quality and Process Improvement Program
More informationManaging & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
More informationPrincipal Investigator Responsibilities for Education and Social/Behavioral Researchers
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal
More informationUniversity of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol
University of Hawai i Human Studies Program Guidelines for Developing a Clinical Research Protocol Following are guidelines for writing a clinical research protocol for submission to the University of
More information12.0 Investigator Responsibilities
v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,
More informationSite visit inspection report on compliance with HTA minimum standards. London School of Hygiene & Tropical Medicine. HTA licensing number 12066
Site visit inspection report on compliance with HTA minimum standards London School of Hygiene & Tropical Medicine HTA licensing number 12066 Licensed under the Human Tissue Act 2004 for the storage of
More informationSTANDARD OPERATING POLICY AND PROCEDURE
STANDARD OPERATING POLICY AND PROCEDURE SUBJECT: Biospecimen Request and Release Policy Number: 500.0 Policy Date: 1/16/2009 Amendment Date: N/A Revision Date: 5-3-2010 I. INTRODUCTION AND PURPOSE The
More informationArchiving of Clinical Trial Data and Essential Documentation JCTO/CT/SOP 4.0. Joint Clinical Trials Office. Stuart Hatcher, JCTO Archivist
Archiving of Clinical Trial Data and Essential Documentation Policy Details Document Type Standard Operating Procedure Document name Change History Date Version Number JCTO/CT/SOP 4.0 Version Final v 2.0-09/11/2010
More informationFDA Presentation - Society for Clinical Research Sites
FDA Presentation - Society for Clinical Research Sites FDA Presentation - Dr. Richard Moscicki, MD FDA CDER Deputy Director for Clinical Research Sites Faculty Disclosure In compliance with ACCME Guidelines,
More informationDocumentation of the Informed Consent Process. USC Office for the Protection of Research Subjects (OPRS)
Documentation of the Informed Consent Process USC Office for the Protection of Research Subjects (OPRS) Session Overview Highlights: Purpose of Informed Consent (IC) IC Process and Documentation Witness
More informationICH CRA Certification Guide March 2009
ICH CRA Certification Guide March 2009 ICH CRA CERTIFICATION GUIDE... 1 GENERAL INFORMATION... 2 BENEFITS OF CERTIFICATION... 2 INDUSTRY RECOGNITION... 2 ABOUT THE EXAM... 2 CRA DEFINITION... 2 REQUIREMENTS
More informationEMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
More informationAdventist HealthCare, Inc.
IRB POLICY ON HUMAN RESEARCH PROTECTION (HRP) AND GOOD CLINICAL PRACTICE (GCP) TRAINING Collaborative Institutional Training Initiative (CITI) Requirements at Adventist Healthcare, Inc. I. Required Human
More informationSTANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE
STANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE UNC OB/GYN (V.1) 9.1.2014 Page i TABLE OF CONTENTS INTRODUCTION. iii ABBREVIATIONS iv GLOSSARY v LISTING OF ATTACHMENTS.... xi I. 1.0 GENERAL ADMINISTRATION
More informationCTMS Protocol Planning, Setup, and Maintenance
CTMS Protocol Planning, Setup, and Maintenance Updated: 09-Jul-2014 Updated: 09-Jul-2014 Page 2 of 22 Table of Contents Protocol Planning and Setup... 6 Protocol Set-Up Process... 6 Protocol Setup Requirements
More informationUniversity of California Davis. Investigator Manual. Revised March 10, 2016
University of California Davis Investigator Manual Revised March 10, 2016 HRP-103 03/10/2016 2 of 41 Table of Contents Scope... 3 What is the purpose of this manual?... 3 What is Human Research?... 3 What
More informationArchiving of Research Documentation
Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment
More informationA New View: How Frequently is GCP Training Needed and What Should Be Included? January 29, 2015
A New View: How Frequently is GCP Training Needed and What Should Be Included? January 29, 2015 1 Increasing the Efficiency of GCP Training Panel Members Speakers: Bridget Foltz, MS, MT(ASCP), U.S. Food
More informationHealth Care Job Information Sheet #20. Clinical Research
Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour
More informationCONDUCTING GLOBAL CLINICAL RESEARCH TRIALS:
CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS: COMPARING AND CONTRASTING FDA MEDICAL DEVICE REGULATIONS FOR CLINICAL INVESTIGATORS WITH ISO 14155:2011 Introduction Today s clinical research landscape for
More information